MediWound Ltd.
MDWD
$16.29
-$0.06-0.37%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -29.48% | 22.59% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -29.48% | 22.59% | |
| Cost of Revenue | -- | -- | 13.33% | 0.94% | |
| Gross Profit | -- | -- | -72.82% | 68.30% | |
| SG&A Expenses | -- | -- | 12.25% | 18.01% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -100.00% | -172.49% | |
| Total Operating Expenses | -- | -- | 0.67% | -1.16% | |
| Operating Income | -- | -- | -107.65% | 36.50% | |
| Income Before Tax | -- | -- | 66.54% | 24.47% | |
| Income Tax Expenses | -- | -- | 137.18% | 664.71% | |
| Earnings from Continuing Operations | -- | -- | 65.73% | 23.75% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | 65.73% | 23.75% | |
| EBIT | -- | -- | -107.65% | 36.50% | |
| EBITDA | -- | -- | -128.16% | 39.70% | |
| EPS Basic | -- | -- | 80.05% | 53.04% | |
| Normalized Basic EPS | -- | -- | 72.38% | 74.12% | |
| EPS Diluted | -- | -- | 80.05% | 53.04% | |
| Normalized Diluted EPS | -- | -- | 72.38% | 74.12% | |
| Average Basic Shares Outstanding | -- | -- | 80.58% | 89.26% | |
| Average Diluted Shares Outstanding | -- | -- | 80.58% | 89.26% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |